The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients (PICS)

This study has been completed.
Sponsor:
Collaborators:
Arthritis and Rheumatic Disease Specialties
UCB Pharma
Information provided by (Responsible Party):
Ewa Olech, Oklahoma Medical Research Foundation
ClinicalTrials.gov Identifier:
NCT01213017
First received: September 29, 2010
Last updated: March 7, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)